Not Such an Excellent Outcome With the FDA
Linkedin

Not Such an Excellent Outcome With the FDA

Alexandria : VA : USA | Nov 01, 2011 at 5:13 PM PDT
Source: The Motley Fool
XX XX
Views: Pending
 
You'd think its lead drug failed a clinical trial or the Food and Drug Administration turned down the drug...Instead, the FDA simply didn't agree with Exelixis in how to take a shortcut to approval. The agency has a process called a Special Protocol Assessment, or SPA, where companies can get the FDA... FULL ARTICLE AT The Motley Fool
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
 
Advertisement
 
Advertisement
 

More From Allvoices

 
Tap_logo_330_110_event
 


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2013. All rights reserved.